Corticosteroid (systemic — SSNHL treatment)
Pregnancy: Use with caution in pregnancy. Lowest effective dose for shortest duration.
Prednisolone (Sudden Sensorineural Hearing Loss)
Brand names: Prednisolone
Adult dose
Dose: 1 mg/kg/day (max 60 mg/day) for 10–14 days, then taper
Route: Oral
Frequency: Once daily (morning)
Max: 60 mg/day
Sudden Sensorineural Hearing Loss (SSNHL): 60 mg/day (or 1 mg/kg/day) for 10–14 days, taper over following 5–7 days. Start within 2 weeks of onset for best outcome. Intratympanic steroid injection (dexamethasone 4–24 mg/mL) may be used if oral contraindicated or as salvage. ENT/audiology urgent referral.
Paediatric dose
Dose: 1 mg/kg
Route: Oral
Frequency: Once daily
Max: 40 mg/day
Children (paediatric ENT specialist): 1 mg/kg/day (max 40 mg/day) for 10–14 days. SSNHL in children is rare and warrants urgent specialist assessment.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution; reduced conversion to active form in severe liver disease.
Paediatric weight-based calculator
Children (paediatric ENT specialist): 1 mg/kg/day (max 40 mg/day) for 10–14 days. SSNHL in children is rare and warrants urgent specialist assessment.
Clinical pearls
- Time-critical: start within 2 weeks for best hearing recovery outcome
- ~50–80% spontaneous recovery rate — steroids improve outcomes further
- Intratympanic dexamethasone: rescue option if oral steroid fails or contraindicated
- Exclude glomus tumour, acoustic neuroma, viral labyrinthitis urgently
- Cover with PPI during short steroid course
Contraindications
- Systemic infection (without antimicrobial cover)
- Peptic ulceration (relative — use PPI)
- Uncontrolled diabetes (relative)
Side effects
- Hyperglycaemia
- Insomnia
- Mood changes
- GI upset
- Fluid retention
- HPA axis suppression (prolonged use)
Interactions
- NSAIDs — increased GI bleeding risk
- Antidiabetics — antagonised glucose-lowering
Monitoring
- Audiometry (pure tone audiogram at baseline and after treatment)
- Blood glucose
- Blood pressure
Reference: BNFc; BNF; NICE CG138; AAO-HNS SSNHL Clinical Practice Guideline. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- HCM Risk-SCD for Hypertrophic Cardiomyopathy · Cardiomyopathy
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Brugada Syndrome Diagnostic Criteria · Channelopathy / Sudden Cardiac Death
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- SIRS Criteria and Sepsis Definition · Sepsis
- Steroid Dose Equivalence · Medications
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020